薦骨神經刺激器市場規模、佔有率和成長分析：按產品類型、應用、技術、最終用戶、分銷管道和地區分類－2026-2033年產業預測

2024 年全球薦骨神經刺激器市值為 1.925 億美元，預計到 2025 年將成長至 2.0212 億美元，到 2033 年將成長至 2.9863 億美元，在預測期（2026-2033 年）內複合年成長率為 5.0%。

全球薦骨神經刺激器市場的發展主要受骨盆底功能障礙盛行率上升以及對旨在緩解膀胱和腸道功能障礙的微創治療需求不斷成長的驅動。患有膀胱過動症和糞便失禁等疾病的患者面臨著生活品質顯著下降和醫療成本飆升的雙重壓力，因此，除了傳統的藥物治療和手術之外，對創新治療方法的需求日益成長。這些技術進步正將治療重點從傳統開放性手術轉向經皮導線測試和MRI相容的可充電植入等前沿解決方案。Medtronic）和Axonics等公司正引領這項變革。此外，技術進步也降低了手術風險和成本，實現了門診治療，並改善了治療效果，尤其對老年患者和尋求造造口替代療法的患者而言更是如此。

全球薦骨神經刺激器市場按產品類型、應用、技術重點、最終用戶、分銷管道和地區進行細分。依產品類型分類，市場分為植入式薦椎神經刺激、體外薦椎神經刺激和其他類型。按應用分類，包括急性尿失禁、大便失禁、慢性肛門裂傷和其他疾病。依技術特性分類，市場分為兼容MRI的系統、人工智慧驅動的封閉回路型演算法、可充電系統和其他類型。依最終用戶分類，市場分為醫院、門診手術中心、專科排泄功能診所和其他機構。按分銷管道分類，包括直接銷售給醫療機構、醫療設備分銷商、線上醫療入口網站和其他管道。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球薦骨神經刺激器市場成長要素

全球薦骨神經刺激器市場的主要促進因素之一是慢性骨盆疼痛和神經源性膀胱疾病盛行率的不斷上升。隨著健康意識的增強，越來越多的患者尋求有效治療方法膀胱過動症、尿失禁和糞便失禁等疾病的方法。除了這些疾病發生率的上升，技術進步也催生了更精密、更微創的刺激技術，推動了對薦骨神經刺激器的需求。此外，個人化醫療的興起以及創新治療方法帶來的患者療效改善，進一步提升了市場成長潛力，並吸引了對該領域的投資和研究。

全球薦骨神經刺激器市場的限制因素

全球薦骨神經刺激器市場的主要限制因素之一是這些醫療設備及其植入手術的高昂費用。有限的保險覆蓋範圍和報銷選擇可能會阻礙患者選擇這種治療方法，尤其是在醫療成本高昂的地區。此外，植入手術的侵入性也可能令患者望而卻步，因為許多患者傾向於選擇非侵入性治療方法。對潛在併發症和持續維護需求的擔憂也是阻礙因素，最終阻礙了市場成長以及醫療服務提供者和患者的接受度。

薦骨神經刺激器全球市場趨勢

全球薦骨神經刺激器市場正呈現微創手術普及的強勁趨勢。外科醫生們正日益接受這些技術，以滿足患者對創傷更小、恢復時間更短、住院時間更短的治療方法的需求。手術器械的改進和專業培訓計畫的引進，使得高品質的手術得以實現，並提升了各醫學專科的手術水準。這一趨勢不僅改善了患者的治療效果，也使薦椎神經刺激療法成為門診治療的可行選擇，從而推動了市場成長和創新。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球薦骨神經刺激器市場規模：依產品類型分類

• 可植入式薦椎神經刺激系統
• 體外薦薦椎神經刺激系統
• 其他

全球薦骨神經刺激器市場規模：按應用領域分類

• 急性尿失禁
• 大便失禁
• 慢性肛門裂傷
• 其他

全球薦骨神經刺激器市場規模：依技術領域分類

• MRI相容系統
• 人工智慧封閉回路型演算法
• 可充電系統
• 其他

全球薦骨神經刺激器市場規模：依最終用戶分類

• 醫院
• 門診手術中心
• 泌尿功能專科診所
• 其他

全球薦骨神經刺激器市場規模：按分銷管道分類

• 直接向醫療機構銷售
• 醫療設備批發商
• 線上醫療入口網站
• 其他

全球薦骨神經刺激器市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Medtronic
• Axonics
• Boston Scientific
• Abbott
• Laborie Medical Technologies
• Nuvectra
• Stimwave
• Neuros Medical
• Nevro
• Mainstay Medical
• Saluda Medical
• Biotronik
• Cyberonics
• Functional Neuromodulation
• SpinePher
• Cogentix Medical
• Uroplasty
• Synapse Biomedical
• Valencia Technologies
• Cirtec Medical

結論與建議

Global Sacral Nerve Stimulator Market size was valued at USD 192.5 Million in 2024 and is poised to grow from USD 202.12 Million in 2025 to USD 298.63 Million by 2033, growing at a CAGR of 5.0% during the forecast period (2026-2033).

The global sacral nerve stimulator market is driven by the increasing prevalence of pelvic floor disorders and the rising demand for minimally invasive treatments aimed at alleviating bladder and bowel dysfunctions. As patients with conditions like overactive bladder and fecal incontinence face significant declines in quality of life and higher healthcare costs, there is a growing need for innovative therapies beyond traditional medications and surgeries. The evolution of these technologies has shifted the focus from open surgical techniques to modern solutions such as percutaneous lead testing and MRI-compatible rechargeable implants. Companies like Medtronic and Axonics are leading this transformation. Furthermore, technological advancements are reducing procedure risks and costs, facilitating outpatient treatments, and enhancing patient outcomes, particularly for the elderly and those seeking alternatives to stoma creation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sacral Nerve Stimulator market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Sacral Nerve Stimulator Market Segments Analysis

The global sacral nerve stimulator market is segmented based on product type, application, technology focus, end-user, distribution channel, and region. By product type, the market is categorized into implantable sacral nerve stimulation systems, external sacral nerve stimulation systems, and others. By application, it includes urge urinary incontinence, fecal incontinence, chronic anal fissure, and others. By technology focus, the segmentation covers MRI-compatible systems, AI-enabled closed-loop algorithms, rechargeable systems, and others. Based on end-users, the market is divided into hospitals, ambulatory surgical centers, specialty continence clinics, and others. By distribution channel, it includes direct institutional sales, medical device distributors, online healthcare portals, and others. Regionally, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Driver of the Global Sacral Nerve Stimulator Market

One of the key market drivers for the global sacral nerve stimulator market is the increasing prevalence of chronic pelvic pain and neurogenic bladder disorders. As healthcare awareness grows, more patients are seeking effective treatment options for conditions such as overactive bladder, urinary incontinence, and fecal incontinence. The rising incidence of these disorders, along with advancements in technology leading to more refined and less invasive stimulation techniques, fuels demand for sacral nerve stimulators. Additionally, the shift towards personalized medicine and improved patient outcomes through innovative therapies further enhances the market's growth potential, attracting investments and research in this field.

Restraints in the Global Sacral Nerve Stimulator Market

One of the key market restraints for the global sacral nerve stimulator market is the high cost associated with these medical devices and their implantation procedures. Limited insurance coverage and reimbursement options can deter patients from opting for this treatment, especially in regions where healthcare costs are a significant concern. Additionally, the invasive nature of the implantation process can lead to patients' reluctance, as many may prefer non-invasive treatment alternatives. Concerns regarding potential complications and the need for ongoing maintenance further contribute to hesitance, thereby inhibiting market growth and adoption rates among healthcare providers and patients alike.

Market Trends of the Global Sacral Nerve Stimulator Market

The Global Sacral Nerve Stimulator market is witnessing a robust trend towards the adoption of minimally invasive procedures. Surgeons are increasingly embracing these techniques, catering to patient preferences for treatments that promise reduced invasiveness, quicker recovery times, and shorter hospital stays. The enhancements in surgical instruments and the implementation of specialized training programs are facilitating high-quality procedural execution, resulting in enhanced surgical proficiency across various medical specialties. This trend not only improves patient outcomes but also positions sacral nerve stimulation as a compelling option within outpatient treatment settings, driving growth and innovation in the market.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Sacral Nerve Stimulator Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Implantable Sacral Nerve Stimulation Systems
• External Sacral Nerve Stimulation Systems
• Others

Global Sacral Nerve Stimulator Market Size by Application & CAGR (2026-2033)

• Market Overview
• Urge Urinary Incontinence
• Fecal Incontinence
• Chronic Anal Fissure
• Others

Global Sacral Nerve Stimulator Market Size by Technology Focus & CAGR (2026-2033)

• Market Overview
• MRI-Compatible Systems
• AI-Enabled Closed-Loop Algorithms
• Rechargeable Systems
• Others

Global Sacral Nerve Stimulator Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Continence Clinics
• Others

Global Sacral Nerve Stimulator Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Institutional Sales
• Medical Device Distributors
• Online Healthcare Portals
• Others

Global Sacral Nerve Stimulator Market Size & CAGR (2026-2033)

• North America (Product Type, Application, Technology Focus, End-User, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Application, Technology Focus, End-User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, Technology Focus, End-User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, Technology Focus, End-User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, Technology Focus, End-User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axonics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laborie Medical Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuvectra
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stimwave
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuros Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mainstay Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Saluda Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyberonics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Functional Neuromodulation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SpinePher
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cogentix Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Uroplasty
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valencia Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cirtec Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations